Anzeige
Mehr »
Mittwoch, 03.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DSA6 | ISIN: SE0009807266 | Ticker-Symbol: 6Y1
Frankfurt
02.06.26 | 08:14
0,688 Euro
+0,58 % +0,004
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTEGRUM AB Chart 1 Jahr
5-Tage-Chart
INTEGRUM AB 5-Tage-Chart

Aktuelle News zur INTEGRUM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
INTEGRUM Aktie jetzt für 0€ handeln
30.04.Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items346Mölndal, Sweden, April 30, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that, as part of preparing the annual financial statements for the 2025/2026 fiscal year...
► Artikel lesen
15.04.Integrum AB: Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare206Mölndal, Sweden, April 15, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Victoria Boiko to coordinate the company's commercial activities in...
► Artikel lesen
05.03.Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26182Mölndal, 5 March 2026 - Integrum (publ) today publishes its interim report for the third quarter 2025/26. During the quarter, the structural transformation was completed and the company now enters the...
► Artikel lesen
03.03.INTEGRUM AB: Integrum invites to presentation of Q3 2025/26 results5
11.02.Integrum AB: Integrum optimizes organization to further accelerate commercialization of OPRA Implant System442Mölndal, Sweden, February 11, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is implementing organizational changes to accelerate the commercialization...
► Artikel lesen
02.12.25Integrum AB: Integrum's rights issue oversubscribed225Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing...
► Artikel lesen
21.11.25Integrum AB: Integrum publishes Interim Report for Q2 2025/26215Second Quarter 2025/26 (August - October) Net sales amounted to SEK 22.3 (21.8) million. Operating result totalled SEK -11.1 (-11.3) million. Profit/loss after tax amounted to SEK -7.4 (-8.9)...
► Artikel lesen
19.11.25True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren360True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft...
► Artikel lesen
13.11.25Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26216Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures...
► Artikel lesen
11.11.25XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025588Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das...
► Artikel lesen
10.11.25Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs210Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term...
► Artikel lesen
23.10.25Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus300Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA...
► Artikel lesen
20.10.25Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum262Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)...
► Artikel lesen
16.10.25Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report297The Board of Directors of Integrum AB (publ) ("Integrum" or the "Company") has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential...
► Artikel lesen
16.10.25Integrum AB: Integrum provides operational update ahead of Q2 report215Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking...
► Artikel lesen
25.09.25The observation status for Integrum AB is removed296On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a...
► Artikel lesen
01.09.25Integrum AB: Stronger positioning paves the way for continued growth189First quarter 2025/26 (May - July) Net sales amounted to SEK 23.8 (18.5) million. Operating loss totalled SEK 12.4 (12.0) million. Profit/loss after tax amounted to SEK -10.0 (-9.4) million. Earnings...
► Artikel lesen
22.07.25Integrum AB: Statement by the independent bid committee of Integrum AB regarding the public takeover offer from OsteoCentric291The independent bid committee of Integrum AB has decided to recommend that the shareholders of Integrum AB accept OsteoCentric Oncology and Bone Anchored Prostheses, LLC's public takeover offer, based...
► Artikel lesen
16.06.25Integrum AB: Integrum appoints Louise Wåhlin as new Chief Financial Officer208Mölndal, Sweden, June 16th, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on...
► Artikel lesen
03.06.25Integrum AB: A rapid shift to full commercial focus152Fourth quarter 2024/25 (February - April) Net sales amounted to SEK 27.1 m (26.1) Operating result amounted to SEK -11.7 m (2.6) Profit/loss after tax amounted to SEK -9.0 m (2.3) Earnings...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1